At Frontiers Health 2025, patient advocate Silvia Cerolini (Eyes on the Future) opened the conference by sharing her story of ...

As part of the 2024 VPAG, there was an agreement to conduct operational review meetings every six months. The first ...

Marking its 10th anniversary, Frontiers Health returns to Berlin at the bcc Berlin Congress Center for a milestone edition bringing together industry leaders, startups, investors, health care systems, ...

Merck KGaA has teamed up with Flagship Pioneering's Valo Health on an ambitious project to apply AI to the discovery of novel ...

Indeed, creating a ‘smart investment strategy’ offers wide-ranging benefits – healthcare providers can innovate, patients ...

Five AI-based technologies that can be used during a colonoscopy exam to help detect the early signs of bowel cancer have ...

A mental health campaigner has condemned the "stunning silence" from mainstream media in the UK after the first-ever men's ...

At ESMO 2025, pharmaphorum had the pleasure of speaking with Michael Lahn, Chief Medical Officer at iOnctura, a ...

Medscape has joined the ranks of companies offering a generative AI chatbot to support clinical decision-making and help ease ...

The FDA has given accelerated approval to Bayer for oral HER2 tyrosine kinase inhibitor sevabertinib as a second-line treatment for advanced HER2-mutant non-small cell lung cancer (NSCLC), allowing it ...

Alongside scientific innovation, ESMO 2025 emphasised the need for global collaboration in regulatory alignment and clinical ...

Roche's oral selective oestrogen receptor degrader (SERD) giredestrant has achieved what the company says is a stellar result ...